Gerry Dolan Selected Research

Hemorrhage

3/2022	A preliminary application of a haemophilia value framework to emerging therapies in haemophilia.
1/2020	Pharmacokinetics in routine haemophilia clinical practice: rationale and modalities-a practical review.
2/2019	Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult-to-treat patients.
9/2018	Practical aspects of extended half-life products for the treatment of haemophilia.
9/2017	Whole exome sequencing identifies a mutation in thrombomodulin as the genetic cause of a suspected platelet disorder in a family with normal platelet function.
1/2017	Beyond stopping the bleed: short-term episodic prophylaxis with recombinant activated factor FVII in haemophilia patients with inhibitors.
1/2009	Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism after total knee and hip replacement surgery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerry Dolan Research Topics

Disease

11	Hemophilia A (Haemophilia) 03/2022 - 04/2015
7	Hemorrhage 03/2022 - 01/2009
2	Joint Diseases (Joint Disease) 09/2018 - 01/2017
2	Hemophilia B (Haemophilia B) 09/2018 - 01/2018
1	Metrorrhagia (Spotting) 05/2021
1	Pain (Aches) 12/2016
1	Arthralgia (Joint Pain) 12/2016
1	Chronic Pain 12/2016
1	Venous Thromboembolism 01/2009
1	Menorrhagia 10/2005
1	Hemostatic Disorders 10/2005

Drug/Important Bio-Agent (IBA)

4	Blood Coagulation Factors (Coagulation Factor)IBA 01/2020 - 01/2018
3	Factor VIII (Coagulation Factor VIII)IBA 02/2019 - 04/2015
2	Factor VIIa (Activated Factor VII)IBA 05/2021 - 01/2017
2	emicizumabIBA 05/2021 - 02/2019
2	Factor IX (Coagulation Factor IX)FDA LinkGeneric 02/2019 - 01/2018
1	EsapentIBA 09/2018
1	Codon (Codons)IBA 09/2017
1	Proteins (Proteins, Gene)FDA Link 09/2017
1	recombinant FVIIa (rFVIIa)FDA Link 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	SteroidsIBA 12/2016
1	Dabigatran FDA Link 01/2009
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2009
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2009
1	Levonorgestrel (Plan B)FDA LinkGeneric 10/2005

Therapy/Procedure

9	Therapeutics 03/2022 - 12/2016
1	Pain Management 12/2016
1	Injections 12/2016
1	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2009
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2009